Nephros (NASDAQ:NEPH – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, November 7th. Investors that are interested in participating in the company’s conference call can do so using this link.
Nephros (NASDAQ:NEPH – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02). The firm had revenue of $3.25 million for the quarter. Nephros had a negative net margin of 9.40% and a negative return on equity of 15.64%.
Nephros Stock Performance
Shares of NASDAQ:NEPH opened at $1.50 on Wednesday. The stock’s 50-day simple moving average is $1.65 and its two-hundred day simple moving average is $1.96. The stock has a market capitalization of $15.81 million, a price-to-earnings ratio of -11.54 and a beta of 1.19. Nephros has a 52-week low of $1.36 and a 52-week high of $4.04.
About Nephros
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Featured Articles
- Five stocks we like better than Nephros
- The How and Why of Investing in Gold Stocks
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- Best Stocks Under $10.00
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.